Wengang Guo Selected Research

Transjugular Intrahepatic Portasystemic Shunt

5/2022	Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS.
1/2022	Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial.
1/2022	Transjugular intrahepatic portosystemic shunt with or without gastro-oesophageal variceal embolisation for the prevention of variceal rebleeding: a randomised controlled trial.
1/2021	Risk Stratification Based on Chronic Liver Failure Consortium Acute Decompensation Score in Patients With Child-Pugh B Cirrhosis and Acute Variceal Bleeding.
1/2021	Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
6/2020	Long-term results of variceal bleeding management in 302 patients with chronic extrahepatic portal vein obstruction.
1/2019	Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.
1/2019	Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic Shunt.
1/2019	Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
1/2019	TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wengang Guo Research Topics

Disease

16	Hemorrhage 01/2022 - 04/2012
14	Fibrosis (Cirrhosis) 05/2022 - 02/2012
11	Thrombosis (Thrombus) 01/2022 - 02/2012
10	Hepatic Encephalopathy 05/2022 - 09/2014
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2013
5	Ascites 01/2022 - 04/2012
4	Portal Hypertension 01/2019 - 04/2012
3	Budd-Chiari Syndrome (Budd Chiari Syndrome) 01/2019 - 09/2014
3	Neoplasms (Cancer) 06/2014 - 01/2013
2	End Stage Liver Disease 05/2022 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 01/2013
1	Dysbiosis 05/2022
1	Gastritis 01/2022
1	Peptic Ulcer (Peptic Ulcers) 01/2022
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 07/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2020
1	Varicose Veins (Varicose Vein) 06/2020
1	Peritonitis 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Hydrothorax 01/2019
1	Hepatorenal Syndrome 01/2019
1	Hepatic Insufficiency 01/2019
1	Spinal Cord Diseases 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Muscle Spasticity (Spastic) 01/2019
1	Idiopathic Noncirrhotic Portal Hypertension 01/2019
1	Brain Diseases (Brain Disorder) 01/2017
1	Hypersplenism (Anemia, Splenic) 06/2012
1	Liver Failure 04/2012
1	Infections 04/2012

Drug/Important Bio-Agent (IBA)

3	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 02/2016
2	BilirubinIBA 05/2022 - 09/2014
2	Propranolol (Inderal)FDA LinkGeneric 01/2019 - 12/2018
1	Biological ProductsIBA 05/2022
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021
1	RivaroxabanIBA 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	AlbuminsIBA 01/2021
1	factor V LeidenIBA 07/2020
1	AntithrombinsIBA 07/2020
1	Protein CIBA 07/2020
1	Prothrombin (Factor II)IBA 07/2020
1	Protein SIBA 07/2020
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 06/2020
1	Serum AlbuminIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2016
1	NitrogenIBA 02/2013
1	Urea (Carbamide)FDA LinkGeneric 02/2013
1	Alkaline PhosphataseIBA 02/2013
1	Glutathione PeroxidaseIBA 01/2013
1	Superoxide DismutaseIBA 01/2013
1	Polysaccharides (Glycans)IBA 01/2013
1	CatalaseIBA 01/2013

Therapy/Procedure

22	Surgical Portasystemic Shunt (Portosystemic Shunt) 05/2022 - 02/2012
21	Transjugular Intrahepatic Portasystemic Shunt 05/2022 - 04/2012
7	Stents 01/2022 - 10/2016
4	Therapeutics 06/2020 - 01/2013
2	Ligation 01/2019 - 12/2018
1	Transplantation 01/2019
1	Thrombolytic Therapy 10/2016
1	Palliative Care (Palliative Therapy) 06/2014
1	Conservative Treatment 01/2014
1	Splenectomy 06/2012